Lysosomal diseases conference - WORLDSymposium 2018 Publicado en: lun, 12 feb 2018 10:47:00 -0500
Recombinant N- Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Enzyme Produced in Pichia pastoris as an alternative for Morquio A ERT
Recombinant N- Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Enzyme Produced in Pichia pastoris as an alternative for Morquio A ERT
Characterization of two potential pharmacological chaperones for N-acetylgalactosamine-6-sulfate sulfatase (GALNS) enzyme.
In-silico assessment of a potential pharmacological chaperone for human GALNS: evaluation in a mutated protein model
  • noticias instituto
   

El profesor Carlos Javier Alméciga Diaz, asístió al pasado Lysosomal diseases conference -  WORLDSymposium 2018 en el que presentó los siguientes trabajos de investigación:

  1. Alexander Rodríguez-López, Luisa N. Pimentel-Vera, Ángela J. Espejo-Mojica, Oscar Hidalgo, Shunji Tomatsu, Carlos J. Alméciga-Díaz. Recombinant N- Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Enzyme Produced in Pichia pastoris as an alternative for Morquio A ERT
  2. Oscar Alejandro Hidalgo, Sergio Olarte-Avellaneda, Alexander Rodríguez-López, Carlos Javier Alméciga-Díaz. Characterization of two potential pharmacological chaperones for N-acetylgalactosamine-6-sulfate sulfatase (GALNS) enzyme.
  3. Sergio Olarte-Avellaneda, Carlos Javier Alméciga-Díaz. In-silico assessment of a potential pharmacological chaperone for human GALNS: evaluation in a mutated protein model